Colorectal Cancer
Conditions
Brief summary
The purpose of this study is to evaluate therapeutic effect of Qigong for muscle strength and quality of life in colorectal cancer patients undergoing chemotherapy.
Detailed description
Muscle weakness and fatigue are prevalent side effects experienced by patients undergoing chemotherapy for colorectal cancer. These symptoms can significantly impact daily functioning and overall quality of life. Finding effective treatments for this condition is crucial to improving patient outcomes and quality of life. Qigong serves as a holistic exercise modality that not only strengthens muscles but also elevates the overall quality of life. Its gentle movements make it accessible to a wide range of individuals, including those undergoing rehabilitation or managing chronic health issues. Furthermore the need of this study is developed from lack in the quantitative knowledge and information in the published studies about the effect of Qigong on muscle strength and quality of life in colorectal cancer patients undergoing chemotherapy.
Interventions
OTHERQigong Exercise
Participants will receive a supervised Baduanjin Qigong exercise program combined with conventional exercises, including pain-free range-of-motion exercises, low-intensity walking, and physical therapy education. The intervention will be conducted three times weekly for 12 weeks under physiotherapist supervision, while participants continue their prescribed chemotherapy and routine medical follow-up.
Participants in this arm will receive a conventional exercise program consisting of pain-free range-of-motion exercises for the shoulder, elbow, wrist, hip, knee, and ankle joints, low-intensity walking, and physical therapy education to maintain daily activities. The intervention will be administered for 12 weeks, with three sessions per week. Participants will continue their prescribed chemotherapy and routine outpatient medical follow-up throughout the study and will not participate in any additional structured exercise program during the intervention period.
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
35 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Age ranges between 35 and 55 years. * Male \& female patients will participate in the study. * All patients with colorectal cancer undergoing chemotherapy. * All patients enrolled to the study will have their informed consent. * The patients will be instructed to report any side effects during the management.
Exclusion criteria
* Presence Patients with psychological disturbance or mental illness. * Cardiopulmonary disease. * Hypotensive patients. * Nerve, muscle, or joint disease, or other malignant tumors affecting movement. * Autoimmune disease.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Muscle Strength | 12 weeks | Muscle strength of the upper and lower limbs will be assessed using the Lafayette Hand-Held Dynamometer. Muscle strength will be quantified as the maximum isometric force generated by the tested muscle groups, with higher values indicating greater muscle strength. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Health-Related Quality of Life | 12 weeks | Health-related quality of life will be assessed using the 36-Item Short Form Health Survey (SF-36). The questionnaire evaluates multiple domains of physical and mental health, with domain scores ranging from 0 to 100. Higher scores indicate better health-related quality of life. |
Countries
Egypt
Contacts
CONTACTShrouk Mohamed Reda Abd Elaliem, M.Sc
CONTACTKhadra Mohammed Ali, PhD
STUDY_CHAIRAmal Mohammed Abd El Baky, PhD
Professor, Cairo University
STUDY_DIRECTORKhadra Mohammed Ali, PhD
Assist Professor, Cairo University
STUDY_DIRECTOREid Rizk El Gamal, PhD
Assist. Professor, Al-Azhar University
Outcome results
None listed